Revumenib Expanded Access Program
Expanded Access Program for SNDX-5613 in Patients With Relapsed/Refractory Acute Leukemias With Genetic Alterations Associated With HOXA Overexpression
More Information
- Trial Status
- Accepting patients
- Sponsors
- Syndax Pharmaceuticals
- Tags
- Menin Inhibitor
- Trial Type
- Expanded Access / Compassionate Use
- Last Update
- 3 months ago
- SparkCures ID
- 1958
- NCT Identifier
- NCT05918913
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.